Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012

Published: September 1, 2020
Category: Bibliography
Authors: Beate Sander, Emily Shing, Frances B. Jamieson, Jeffrey C. Kwong, John Wang, Lauren C. Ramsay, Sarah K. Brode, Theodore K. Marras
Countries: Canada
Language: English
Types: Finance/Budgeting, Population Health
Settings: Government, Health Plan



To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective


We conducted a population-based matched cohort study in Ontario, Canada. We established cohorts of patients with incident NTM-PD and NTM-PI during 2001–2012 by using individually linked laboratory data and health administrative data, matched to unexposed persons from the general population. To estimate attributable costs for acute and long-term illness, we used a phase-of-care approach. Costs were stratified by age, sex, and healthcare resource, and reported in 2018 Canadian dollars (CAD) and US dollars (USD), standardized to 10 days.


Costs were highest during the before-death phase (NTM-PD CAD $1,352 [USD $1,044]; NTM-PI CAD $731 [USD $565]). The cumulative mean attributable 1-year costs were CAD $14,953 (USD $11,541) for NTM-PD and CAD $8,729 (USD $6,737) for NTM-PI.


Costs for patients with NTM-PD and NTM-PI were higher than those for unexposed persons.

tuberculosis and other mycobacteria,nontuberculous mycobacteria,cost, pulmonary disease,NTM pulmonary disease,NTM pulmonary isolation,Ontario, Canada,bacteria

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top